Suppr超能文献

血液制品中的纤连蛋白——一项体外和体内研究。

Fibronectin in blood products--an in vitro and in vivo study.

作者信息

Reilly J T, McVerry B A, Mackie M J

出版信息

J Clin Pathol. 1983 Dec;36(12):1377-81. doi: 10.1136/jcp.36.12.1377.

Abstract

The concentration of fibronectin was assessed in a variety of coagulation factor preparations. Highest concentrations of fibronectin were found in the intermediate purity factor VIII concentrates. Significant amounts were found in cryoprecipitate but high purity factor VIII concentrates contained only small amounts. For practical purposes factor IX concentrates contained no fibronectin. Qualitative estimation of fibronectin showed the presence of an abnormal slow migrating peak on 2 DIEP which was not found in normal plasma. In vivo recovery infused fibronectin was relatively low for all products studied (30-54%). The plasma half life (17-25 h) did not differ significantly depending on whether cryoprecipitate or a factor VIII concentrate was used as a source of fibronectin. No enhancement of plasma fibronectin concentrations was obtained following DDAVP infusion, venous occlusion and exercise. Plasma fibronectin concentrations and 2 DIEP patterns were unaltered following prolonged storage.

摘要

在多种凝血因子制剂中评估了纤连蛋白的浓度。在中等纯度的因子VIII浓缩物中发现纤连蛋白浓度最高。冷沉淀中发现了大量纤连蛋白,但高纯度因子VIII浓缩物中仅含有少量。实际上,因子IX浓缩物中不含纤连蛋白。纤连蛋白的定性评估显示,在二维免疫电泳上存在一个异常的缓慢迁移峰,而在正常血浆中未发现此峰。对于所有研究的产品,输注的纤连蛋白的体内回收率相对较低(30-54%)。无论使用冷沉淀还是因子VIII浓缩物作为纤连蛋白的来源,血浆半衰期(17-25小时)均无显著差异。输注去氨加压素、静脉阻塞和运动后,血浆纤连蛋白浓度未升高。长期储存后,血浆纤连蛋白浓度和二维免疫电泳图谱未改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2dd/498572/3cceb7c97c46/jclinpath00517-0058-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验